期刊
MOLECULAR CARCINOGENESIS
卷 54, 期 10, 页码 1147-1158出版社
WILEY
DOI: 10.1002/mc.22185
关键词
HSP90; ganetespib; EMT; metastasis; colorectal cancer
资金
- Georgia Cancer Coalition [00026700]
- Kennedy Award [00015855]
- Cancer.gov [NCT 01554969]
Epithelial to mesenchymal transition (EMT), invasion, and motility are essential steps in colorectal cancer (CRC) metastasis regulated by HIF-1 alpha and NF-kappa B. Since HSP90 activates HIF-1 alpha and NF-kappa B, we hypothesized that inhibition of HSP90 leads to inhibition of HIF-1 alpha and NF-kappa B resulting in inhibition of EMT, invasion, and motility. Treatment of colorectal cancer cell lines HT-29 and HCT-116 with ganetespib at 50nM for 24 h inhibited EMT (downregulated vimentin and upregulated E-cadherin), matrigel invasion, and spheroid migration. Ganetespib treatment or HSP90 knockdown downregulated molecular pathways associated with EMT, invasion, and motility. The overexpression of HIF-1 alpha or NF-kappa B resulted in increased EMT, invasion, and motility in both cell lines and these effects were inhibited by ganetespib. Similar effects were observed in animal xenografts treated with ganetespib. Taken together, our data demonstrate for the first time that inhibition of HSP90 downregulates both HIF-1 alpha and NF-kappa B leading to inhibition of EMT, motility, and invasiveness in colorectal cancer. (C) 2014 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据